Coronavirus vaccine update: Wednesday, June 17

On Wednesday, Gilead Sciences announced that it would soon begin enrolling volunteers for the next phase of its Remdesivir trial. Yahoo Finance’s Anjalee Khemlani breaks down the latest news about Gilead Science’s trial on The Final Round.